Lantheus Holdings, Inc.

LNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013
Operating Activities
Net Income $123.4M $26.8M $-14.7M $-3.6M $-61.6M
Depreciation & Amortization $19.2M $18.3M $19.7M $19.0M $25.8M
Depreciation — $800.0K $11.8M $9.9M $9.3M
Amortization $3.3M $5.1M $6.0M $7.6M $14.4M
Stock-Based Compensation $5.9M $2.5M $2.0M $1.0M $578.0K
Net Cash from Operating Activities $54.8M $49.6M $21.8M $11.6M $-15.6M
Investing Activities
Capital Expenditures $17.5M $7.4M $13.2M $8.1M $5.0M
Business Acquisitions — — — — —
Net Cash from Investing Activities $-16.3M $3.3M $-13.2M — —
Financing Activities
Dividends Paid — — — — $123.0K
Stock Repurchases — — — — $106.0K
Net Cash from Financing Activities $-13.5M $-30.2M $999.0K — —
Net Change in Cash $25.1M $22.6M $8.9M $1.2M $-14.7M
Free Cash Flow $37.2M $42.2M $8.6M $3.5M $-20.6M
← Newer Page 2 of 2 Older →